Cytodyn Inc (CYDY)

[daemon57]

Interesting FDA guidelines for MAB revision: https://www.fda.gov/drugs/drug-safety-and-availability/fda-authorizes-revisions-fact-sheets-address-sars-cov-2-variants-monoclonal-antibody-products-under

"Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens such as viruses, like SARS-CoV-2. The mAb therapies are currently authorized by FDA to treat mild to moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or hospitalization."

NO PUMP here BUT WHERE IN THE WORLD IS THE GUIDELINES FOR SEVERE TO CRITICAL PATIENTS??

Coincidental that they revised it? IDK, you tell me..

GLTU/A.